When it comes to COVID-19 testing in the United States, the situation is about as messy as it gets. The U.S. went from having no tests, or assays, available for … Continue Reading There are many COVID-19 tests in the US – how are they being regulated?
Adam Schlifke, Founder & CEO, COVIDvent, Stanford School of Medicine Host: David Cao, F50 F50 Global Insights Adam Schlifke, MD, MBA is a board certified anesthesiologist with more than 15 … Continue Reading Supporting the care of COVID+ patients at home with a digital health platform – Adam Schlifke
Amid the chaos of an epidemic, those who survive a disease like COVID-19 carry within their bodies the secrets of an effective immune response. Virologists like me look to survivors … Continue Reading Antibodies in the blood of COVID-19 survivors know how to beat coronavirus – and researchers are already testing new treatments that harness them
Panel: Social Impacts of Longevity Seth Sternberg, Co-Founder & CEO, Honor Mark Silverman, Founder & CEO, Amava Moderator: Amy Yotopoulos, Gerontologist, Stanford
Lukas Kopacki, home from college after the coronavirus pandemic closed his campus, was feeling lousy for days with headaches, sore throat and difficulty breathing through his nose. But he worried … Continue Reading Telemedicine Surges, Fueled By Coronavirus Fears And Shift In Payment Rules
F50 Global Insights presents Covid19 Home Shelter Policy by Bay Area Authority – Impact on Startups & Business’ by Sean Randolph, Senior Director, Bay Area Council Economic Institute, Bay Area … Continue Reading Sean Randolph: COVID-19 Impact on Startups & Business in Bay Area
A century ago, on July 26, 1916, a viral disease swept through New York. Within 24 hours, new cases of polio increased by more than 68%. The outbreak killed more … Continue Reading Coronavirus: A new type of vaccine using RNA could help defeat COVID-19
The coronavirus has ground social, economic and educational exchanges to a halt around the world. For now, public health officials are relying on tools like social distancing to minimize the … Continue Reading Labs are experimenting with new – but unproven – methods to create a coronavirus vaccine fast
The ‘Home Shelter Policy’ announced yesterday by Bay Area Authorities to control COVID-19 outbreak and developing situation has created lots of challenges and uncertainty to the founders and investors in … Continue Reading COVID-19:Elevating HealthTech Innovation @ F50 Global Insights
CDC (Centers for Disease Control and Prevention, part of the U.S. Health and Human Services Department) cases in the U.S. information for businesses, schools, and communities travel FAQs information for … Continue Reading COVID-19 (SARS-CoV-2) Information Sources Collection
The race is on to identify an effective vaccine for the COVID-19 virus. Once discovered, the next challenge will be manufacturing and distributing it around the world. My research group … Continue Reading Vaccines without needles – new shelf-stable film could revolutionize how medicines are distributed worldwide
Pavan Kumar Partner @ F50. Original on Linkedin The stark reality is, we are caught off guard and its ripple effect will impact the global commerce, economies and enterprises in … Continue Reading Corona Virus & Emerging Opportunities
Nearly 100,000 pop culture fans flocked to Emerald City Comic Con in Seattle last year, including many dressed as superheroes, aliens and robots. But something scarier than a comic book … Continue Reading With Coronavirus Lurking, Conferences Wrestle With Whether To Cancel
Can’t see the audio player? Click here to listen on SoundCloud. Julie Rovner Kaiser Health News @jrovner Read Julie’s Stories Joanne Kenen Politico @JoanneKenen Read Joanne’s Stories Kimberly Leonard Washington … Continue Reading Prepping For A Possible Pandemic – Kaiser Health Podcast
Canadian artificial intelligence firm BlueDot has been in the news in recent weeks for warning about the new coronavirus days ahead of the official alerts from the Centers for Disease … Continue Reading Predicting the coronavirus outbreak: How AI connects the dots to warn about disease threats